1 – 10 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Afadin cooperates with Claudin-2 to promote breast cancer metastasis
- 2018
- Ghrelin expression is associated with a favorable outcome in male breast cancer
- Claudin-4 Expression is Associated with Survival in Ovarian Cancer but Not with Chemotherapy Response
- Abstract P3-02-02: Concordance between immunohistochemical and gene-expression based subtyping of early breast cancer using core needle biopsies and surgical specimens - experices from SCAN-B
- Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer
- Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer
- Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
- 2017
- Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread : A case control study
- A case-matched gender comparison transcriptomic screen identifies eIF4E and eIF5 as potential prognostic markers in male breast cancer
- An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression